TSND.TO TERRASCEND CORP
$0.87▼ -1.14%
Healthcare
Other
Volume 82.0K
Avg Volume (10D) 192.6K
Key Metrics & Fundamentals
Market Cap
$324.22M
P/E Ratio
–
Div Yield
–%
52W Range
0.53 - 2.00
% vs 50 MA
6.57%
% vs 200 MA
-4.41%
RSI-14
51.1
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.29
Free Cash Flow
$4.94M
Gross Rev
$67.12M
Gross Profit
$36.25M
EBITDA
$16.88M
COGS
$30.87M
Operating Exp
$24.14M
Operating Income
$12.11M
EBIT
$12.11M
Pretax Income
$1.53M
Net Income
-$9.16M
EPS (Diluted)
-0.03
Price & Volume History
Loading chart…
Recent News
TerrAscend to Participate in the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference
GlobeNewswire · Sep 4, 2026 4:30 PM
WD-40 Appoints Keith Stauffer as CFO
MT Newswires · Sep 3, 2026 9:48 PM
TerrAscend Announces Results of Special Meeting of Shareholders
GlobeNewswire · Aug 24, 2026 10:07 PM
TerrAscend to Renew $10 Million Share Repurchase Program
MT Newswires · Aug 20, 2026 1:56 PM
TerrAscend Announces Renewal and Replenishment of $10 Million Share Repurchase Program
GlobeNewswire · Aug 20, 2026 1:30 PM
TerrAscend Reports Wider Loss, Higher Revenue for Second Quarter
MT Newswires · Aug 6, 2026 8:35 PM
TerrAscend Reports Second Quarter 2026 Financial Results
GlobeNewswire · Aug 6, 2026 8:10 PM
TerrAscend to Host Second Quarter 2026 Earnings Conference Call
GlobeNewswire · Jul 16, 2026 12:30 PM
TerrAscend to Buy 5th Dispensary in New Jersey For $9 Million
MT Newswires · Jun 30, 2026 1:11 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See TSND.TO's money flow as a full page
Social Sentiment
No Reddit posts found for TSND.TO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.